Neuroendocrine Differentiation in Large-Cell Bronchial Carcinomas
Author Information
Author(s): Wolfgang Jungraithmayr, Gian Kayser, Bernward Passlick, Stephan Eggeling
Primary Institution: University Hospital Freiburg
Hypothesis
What is the clinical behavior and prognosis of large-cell bronchial carcinomas with neuroendocrine morphology compared to those expressing neuroendocrine markers?
Conclusion
Large-cell neuroendocrine carcinomas of the lung show aggressive behavior with a poor prognosis, particularly in those expressing neuroendocrine markers.
Supporting Evidence
- The median survival for patients with neuroendocrine morphology was 30 months, while it was 20 months for those with neuroendocrine markers.
- Recurrences in the neuroendocrine morphology group were exclusively intrapulmonary, while those in the neuroendocrine markers group were distant metastases.
Takeaway
This study looked at two types of lung cancer and found that one type is much more aggressive and has a worse outcome than the other.
Methodology
The study analyzed clinical data and pathological examinations of 12 patients who underwent surgery for large-cell bronchial carcinomas.
Potential Biases
No formal statistical analysis was conducted due to the small number of patients.
Limitations
The small sample size limits the ability to generalize the findings.
Participant Demographics
1 female and 11 male patients, mean age 65 years (range 41-80).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website